Mucolin (Ambroxol Hydrochloride)

Ambroxol Hydrochloride increases serous secretion in the respiratory tract, stimulates surfactant production and enhances ciliary activity. These actions reduce mucus viscosity and promote mucociliary clearance, allowing easier expectoration of sputum and improving airway ventilation.

The appropriate dose of Mucolin is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and overall health status. Patients should follow the prescriber’s instructions and the product label.

Safety of Ambroxol Hydrochloride in pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Mucolin.

To order Mucolin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mucolin’s active ingredient, Ambroxol Hydrochloride, is a well‑studied mucolytic that not only thins mucus but also stimulates surfactant production and ciliary activity. Compared with agents such as acetylcysteine, Ambroxol may have a more pronounced effect on mucus clearance and fewer gastrointestinal side effects, though individual response can vary.

Mucolin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and efficacy.

Mucolin is administered orally. The tablet or liquid should be taken with water as directed by the prescriber, usually after meals to minimise gastrointestinal discomfort, unless otherwise instructed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, hepatic dysfunction, eosinophilia and persistent bronchospasm. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or jaundice.

Mucolin should be avoided in individuals with known hypersensitivity to Ambroxol Hydrochloride or any excipients in the formulation. Patients with severe renal impairment, uncontrolled asthma, or a history of severe allergic reactions should consult a healthcare professional before use.